Forget Privacy During Online Health Searches
Tracking your search information is not just the business of the NSA and major technology companies. Medical information websites collect search queries and leak information to third parties too.
Tracking your search information is not just the business of the NSA and major technology companies. Medical information websites collect search queries and leak information to third parties too.
Of 20 free-to-use health sites, all of them had at least one “third-party element,” reports USC professor Dr. Marco Huesch. Some sites had at least six or seven.
Five sites that included a tracking function by third parties also included a social media “share” button that followed a user’s search even if the user did not click the button.
“Many users assume their online search inquiries are anonymous, but code on the website, such as social-media plug-ins, and dropped on the user’s computer, such as cookies, can divulge this data to third parties,” MedPage Today reported.
— Posted by Alexander Reed Kelly.
Your support matters…MedPage Today:
Among five of the 13 sites with tracking elements, social media-related tracking elements were embedded that shared a user’s data with a social media site whether or not the user was logged into a given social media site and regardless of whether the user chose to interact with the social media feature (such as by “liking” or “sharing” a page).
Through a data interception tool, search queries were leaked to third-party tracking elements on seven of the sites, which did not include government or physician-oriented sites.
[Huesch] concluded that although the information gathered through third-party affiliates “enhances the online user’s experience and allows targeted advertisements, which support a free business model,” many of these data-mining methods can compromise a user’s privacy and “are insufficiently addressed in current legislation and regulations.”
“Were such risks to be realized, the ramifications could span embarrassment, discrimination in the labor market, or the deliberate decision by marketers not to offer or advertise particular goods and services to an individual,” he added.
The results also suggested that government- and professional society-related websites may be safer search beacons than those of commercial or mass-media sites.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Half of U.S. physicians are “disengaged, burned out, and demoralized and plan to either retire, cut back on work hours, or seek non-clinical roles,” according to a new survey.Half of physicians nationwide are “disengaged, burned out, and demoralized and plan to either retire, cut back on work hours, or seek non-clinical roles,” according to a new survey.
Medical societies and paid drug industry researchers have loaded society up with new definitions of alleged ill health from which drug companies can profit when millions of otherwise well people are labeled as ailing.
Wall Street’s drive for profits is diminishing the benefits to society of new life-enhancing medications for which companies can charge patients hundreds of thousands of dollars per year.
A recent study showed that the highest rates of burnout in the medical profession were found among front-line physicians: family doctors, internal specialists, neurologists and -- in particular -- emergency MDs.
The first large analysis of takotsubo, or “broken-heart syndrome,” shows that the condition can be just as deadly as other cardiovascular diseases -- and that most victims are female.
Though Humulin has been on the market for many years for a relatively cheap price, a single monthlong dose of the insulin variety manufactured by Eli Lilly costs $1,200 today -- more than five times the amount in 2007. Why? Because the company can charge that much, Eli Lilly's insulin marketing director said.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.